Bibliography
- SCHANTZ EJ, ROESSLER WG, WAGMAN J, SPERO L, DUNNERY DA, BERGDOLL MS: Purification of staphylococcal enterotoxin B. Biochemistry (1965) 4(6):1011–1016.
- MARRACK P, KAPPLER J: The staphylococcal superantigens and their relatives. Science (1990) 248:705–711.
- HERMAN A, KAPPLER J, MARRACK P et al.: Superantigens: mechanism of T cells stimulation and role in immune responses. Ann. Rev. Immunol. (1991) 9:745–772.
- PROFT T, FRASER JD: Bacterial superantigens. Clin. Exp. Immunol (2003) 133:299–306.
- CHOI Y, LAFFERTY JA, CLEMENTS JR et al.: Selective expansion of T cells expressing V02 in toxic shock syndrome. J. Exp. Med. (1990) 3:981–984.
- ABRAHAM E, ANZUETO A, GUTIERREZ G et al.: Double-blind randomised trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet (1998) 351:929–933.
- PANACEK EA, MARSHALL JC, ALBERTSON TE et al.: Monoclonal anti-TNFa randomized controlled sepsis study investigators. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit. Care Med. (2004) 32(1 0:2173–2178.
- VISVANATHAN K, CHARLES A, BANNAN J, PUGACH P, KASHFI K, ZABRISKIE JB: Inhibition of bacterial superantigens by peptides and antibodies. Infect. Immun. (2001) 69(2):875–884.
- SHUPP JW, JETT M, PONTZER CH: Identification of a transcytosis epitope on staphylococcal enterotoxins. Infect. Immun. (2002) 70(4):2178–2186.
- ARAD G, LEVY R, HILLMAN D, KAEMPFER R: Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat. Med. (2000) 6(4):414–421.
- RAJAGOPALAN G, SEN MM, DAVID CS: In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists. Infect. Immun. (2004) 72(11):6733.
- KIEKE MC, SUNDBERG E, SHUSTA EV, MARIUZZA RA, WITTRUP KD, KRANZ DM: High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J. Md. Bid. (2001) 307(5):1305–1315.
- NASRAWAY SA: The problems andchallenges of immunotherapy in sepsis. Chest (2003) 123\(Supp1.5):451S–459S.